Related Experiment Video
Updated: Sep 14, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral annular calcification in severe aortic stenosis: prognostic value of calcification severity and mitral valve
Pierre Vanhaecke1, Yohann Bohbot1,2, Emilion Hucleux1
1Department of Cardiology, Amiens University Hospital, Avenue René Laënnec, 80054 Cedex 1, Amiens, France.
Insights
Mitral annular calcification (MAC) is common in patients with severe aortic stenosis (AS), impacting survival. Severe MAC or co-occurring mitral valve dysfunction (MVD) significantly reduces long-term survival in these patients.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Echocardiography
Background:
- Mitral annular calcification (MAC) is frequently observed in patients with severe aortic stenosis (AS).
- The prognostic implications of MAC severity and concurrent mitral valve dysfunction (MVD) in severe AS are not fully understood.
Purpose of the Study:
- To investigate the impact of MAC severity and MVD on patient outcomes in severe AS.
Main Methods:
- Retrospective analysis of 613 patients with severe AS.
- Categorization based on echocardiographic MAC severity and presence of MVD (mean transmitral gradient ≥5 mmHg).
Main Results:
- Over 50% of patients had MAC; 21% had MVD. MAC was associated with reduced six-year survival (47% vs. 64%).
- Severe MAC and MVD independently predicted mortality (HRs 2.63 and 1.86, respectively).
- Patients with severe MAC or concomitant MVD had significantly lower survival rates.
Conclusions:
- MAC is highly prevalent in severe AS and is linked to decreased survival.
- Evaluating MAC severity and MVD is crucial for risk stratification and clinical decision-making in AS patients.
Aims:
Mitral annular calcification (MAC) is common in patients with severe aortic stenosis (AS); however, the impact of its severity and associated mitral valve dysfunction (MVD) on patient outcomes remains unclear. This study aims to assess the influence of MAC severity and MVD on outcomes in individuals with severe AS.
Methods And Results:
This retrospective study included 613 patients with severe AS. Patients were categorized by echocardiographic MAC severity and the presence of MVD, defined as a mean transmitral gradient (mTMG) ≥ 5 mmHg. In total, 309 (50.4%) of the 613 patients had MAC (44% mild, 40% moderate, and 16% severe), and 21% also displayed MVD. Patients with MAC had a lower 6-year survival (47 ± 3% vs. 64 ± 3%, log-rank P < 0.001) even after adjustment for covariates with prognostic impact {hazard ratio [HR] [95% confidence interval (CI)] = 1.24 [1.03-1.67]}. Severe MAC was associated with being older, being female, higher comorbidity scores, and high pulmonary pressures (all P < 0.05) and with a lower 6-year survival (23 ± 7%) than mild (55 ± 5%) or moderate MAC (50 ± 5%). Patients with both MAC and MVD had a 6-year survival of 28 ± 7%, markedly lower than the 53 ± 4% for those with MAC but not MVD. Multivariable analysis indicated that severe MAC [HR (95% CI) = 2.63 (.51-4.60)] and MVD [HR (95% CI) = 1.86 (1.24-2.77)] were independent predictors of death.
Conclusion:
MAC is highly prevalent in patients with severe AS, affecting more than 50%. It is associated with shorter survival, particularly if MAC is severe or the patient also has MVD. These findings highlight the importance of evaluating MAC severity and mTMG in AS patients to guide clinical decisions.
More Related Videos
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
05:47Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis III: Medical Management